Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation (ASCT) in previously untreated patients with peripheral T-cell lymphoma (PTCL). Results of a prospective phase II study from the GELCAB.

被引:6
|
作者
Lopez-Guillermo, A [1 ]
Mercadal, S [1 ]
Briones, J [1 ]
Xicoy, B [1 ]
Pedro, C [1 ]
Escoda, L [1 ]
Estany, C [1 ]
Camos, M [1 ]
Ribera, JM [1 ]
Martino, R [1 ]
Montserrat, E [1 ]
机构
[1] GELCAB, Grp Estudi Limformes Catalunya & Balears, Barcelona, Spain
关键词
D O I
10.1182/blood.V106.11.2077.2077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2077
引用
收藏
页码:587A / 588A
页数:2
相关论文
共 50 条
  • [1] Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
    Mercadal, S.
    Briones, J.
    Xicoy, B.
    Pedro, C.
    Escoda, L.
    Estany, C.
    Camos, M.
    Colomo, L.
    Espinosa, I.
    Martinez, S.
    Ribera, J. M.
    Martino, R.
    Gutierrez-Garcia, G.
    Montserrat, E.
    Lopez-Guillermo, A.
    ANNALS OF ONCOLOGY, 2008, 19 (05) : 958 - 963
  • [2] Is there a role for autologous stem-cell transplantation (ASCT) in peripheral T-Cell lymphoma (PTCL)? Final results of a prospective phase II study from the GELCAB.
    Mercadal, Santiago
    Lopez-Guillermo, Armando
    Briones, Javier
    Xicoy, Blanca
    Pedro, Carme
    Escoda, Lourdes
    Estany, Cristina
    Camos, Mireia
    Ribera, Josep-Maria
    Martino, Rodrigo
    Colomo, Llms
    Montserrat, Emili
    BLOOD, 2006, 108 (11) : 874A - 875A
  • [3] Treatment of peripheral T-cell lymphoma (PTCL) with high-dose chemotherapy and autologous stem cell transplantation (ASCT).
    Kim, Min Kyoung
    Kim, Shin
    Lee, Seoung Sook
    Sym, Sun Jin
    Lee, Dae Ho
    Kim, Sang We
    Jang, Seongsoo
    Park, Chan Jeong
    Chi, Hyun Sook
    Huh, Joo Ryung
    Sub, Cheolwon
    BLOOD, 2006, 108 (11) : 252B - 252B
  • [4] Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
    Annalisa Chiappella
    Anna Dodero
    Andrea Evangelista
    Alessandro Re
    Lorella Orsucci
    Sara Veronica Usai
    Claudia Castellino
    Vittorio Stefoni
    Antonio Pinto
    Manuela Zanni
    Rosanna Ciancia
    Chiara Ghiggi
    Francesca Gaia Rossi
    Annalisa Arcari
    Fiorella Ilariucci
    Vittorio Ruggero Zilioli
    Leonardo Flenghi
    Melania Celli
    Stefano Volpetti
    Fabio Benedetti
    Filippo Ballerini
    Gerardo Musuraca
    Riccardo Bruna
    Caterina Patti
    Francesco Leonardi
    Luca Arcaini
    Massimo Magagnoli
    Federica Cavallo
    Anisa Bermema
    Alessandra Tucci
    Carola Boccomini
    Giovannino Ciccone
    Cristiana Carniti
    Stefano Aldo Pileri
    Paolo Corradini
    Leukemia, 2023, 37 : 433 - 440
  • [5] Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
    Chiappella, Annalisa
    Dodero, Anna
    Evangelista, Andrea
    Re, Alessandro
    Orsucci, Lorella
    Usai, Sara Veronica
    Castellino, Claudia
    Stefoni, Vittorio
    Pinto, Antonio
    Zanni, Manuela
    Ciancia, Rosanna
    Ghiggi, Chiara
    Rossi, Francesca Gaia
    Arcari, Annalisa
    Ilariucci, Fiorella
    Zilioli, Vittorio Ruggero
    Flenghi, Leonardo
    Celli, Melania
    Volpetti, Stefano
    Benedetti, Fabio
    Ballerini, Filippo
    Musuraca, Gerardo
    Bruna, Riccardo
    Patti, Caterina
    Leonardi, Francesco
    Arcaini, Luca
    Magagnoli, Massimo
    Cavallo, Federica
    Bermema, Anisa
    Tucci, Alessandra
    Boccomini, Carola
    Ciccone, Giovannino
    Carniti, Cristiana
    Pileri, Stefano Aldo
    Corradini, Paolo
    LEUKEMIA, 2023, 37 (02) : 433 - 440
  • [6] The impact of disease status on the outcome of high-dose therapy (HDT) and autologous stem cell transplantation (ASCT) for peripheral T-Cell lymphoma (PTCL).
    Nademanee, Auaypom P.
    Zain, Jasmine M.
    Palmer, Joycelynne
    Tsai, Nicole
    Kogut, Neil Martin
    Krishnan, Arnrita
    Popplewell, Leslie
    Rodriguez, Roberto
    Smith, Eileen Patricia
    Forman, Stephen J.
    BLOOD, 2006, 108 (11) : 871A - 871A
  • [7] High-dose therapy supported by autologous stem cell transplantation (ASCT) in patients with peripheral T-cell lymphoma (PTCL): A nation-wide survey from Finland
    Jantunen, E
    Wiklund, T
    Putkonen, M
    Juvonen, E
    Lehtinen, T
    Kuittinen, O
    Nousiainen, T
    BONE MARROW TRANSPLANTATION, 2002, 29 : S88 - S88
  • [8] High-dose chemotherapy (HDCT) with peripheral autologous stem cell transplantation (PBSCT) in patients with peripheral T-cell lymphoma.
    Reimer, P
    Braun, M
    Weissinger, F
    Rüdiger, T
    Müller-Hermelink, HK
    Wilhelm, M
    BLOOD, 2000, 96 (11) : 375B - 375B
  • [9] Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen
    Smith, S. D.
    Bolwell, B. J.
    Rybicki, L. A.
    Brown, S.
    Dean, R.
    Kalaycio, M.
    Sobecks, R.
    Andresen, S.
    Hsi, E. D.
    Pohlman, B.
    Sweetenham, J. W.
    BONE MARROW TRANSPLANTATION, 2007, 40 (03) : 239 - 243
  • [10] Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen
    S D Smith
    B J Bolwell
    L A Rybicki
    S Brown
    R Dean
    M Kalaycio
    R Sobecks
    S Andresen
    E D Hsi
    B Pohlman
    J W Sweetenham
    Bone Marrow Transplantation, 2007, 40 : 239 - 243